nodes	percent_of_prediction	percent_of_DWPC	metapath
Etodolac—PTGS2—melanoma	0.317	0.529	CbGaD
Etodolac—ALB—melanoma	0.282	0.471	CbGaD
Etodolac—ALB—Vemurafenib—melanoma	0.0187	1	CbGbCtD
Etodolac—Pharyngitis—Dactinomycin—melanoma	0.000628	0.00313	CcSEcCtD
Etodolac—Stomatitis—Temozolomide—melanoma	0.000621	0.0031	CcSEcCtD
Etodolac—Deafness—Docetaxel—melanoma	0.000615	0.00307	CcSEcCtD
Etodolac—Hepatic failure—Docetaxel—melanoma	0.000612	0.00305	CcSEcCtD
Etodolac—Chills—Bleomycin—melanoma	0.000609	0.00304	CcSEcCtD
Etodolac—Cardiac failure congestive—Docetaxel—melanoma	0.000607	0.00303	CcSEcCtD
Etodolac—Alopecia—Bleomycin—melanoma	0.0006	0.00299	CcSEcCtD
Etodolac—Erythema multiforme—Dactinomycin—melanoma	0.000598	0.00298	CcSEcCtD
Etodolac—Sinusitis—Temozolomide—melanoma	0.000598	0.00298	CcSEcCtD
Etodolac—Haemoglobin—Carmustine—melanoma	0.000595	0.00297	CcSEcCtD
Etodolac—Haemorrhage—Carmustine—melanoma	0.000592	0.00295	CcSEcCtD
Etodolac—Hallucination—Carmustine—melanoma	0.000589	0.00294	CcSEcCtD
Etodolac—Flushing—Dactinomycin—melanoma	0.000587	0.00293	CcSEcCtD
Etodolac—Hypersensitivity—Vemurafenib—melanoma	0.000586	0.00292	CcSEcCtD
Etodolac—Visual disturbance—Docetaxel—melanoma	0.000581	0.0029	CcSEcCtD
Etodolac—Renal impairment—Docetaxel—melanoma	0.000578	0.00288	CcSEcCtD
Etodolac—Dermatitis bullous—Docetaxel—melanoma	0.000576	0.00287	CcSEcCtD
Etodolac—Haemoglobin—Temozolomide—melanoma	0.000575	0.00287	CcSEcCtD
Etodolac—Haemorrhage—Temozolomide—melanoma	0.000572	0.00285	CcSEcCtD
Etodolac—Hepatitis—Temozolomide—melanoma	0.000572	0.00285	CcSEcCtD
Etodolac—Asthenia—Vemurafenib—melanoma	0.000571	0.00285	CcSEcCtD
Etodolac—Visual impairment—Carmustine—melanoma	0.000571	0.00285	CcSEcCtD
Etodolac—Hallucination—Temozolomide—melanoma	0.000569	0.00284	CcSEcCtD
Etodolac—Pharyngitis—Temozolomide—melanoma	0.000568	0.00283	CcSEcCtD
Etodolac—Chills—Dactinomycin—melanoma	0.000568	0.00283	CcSEcCtD
Etodolac—Pruritus—Vemurafenib—melanoma	0.000563	0.00281	CcSEcCtD
Etodolac—Alopecia—Dactinomycin—melanoma	0.000559	0.00279	CcSEcCtD
Etodolac—Visual impairment—Temozolomide—melanoma	0.000552	0.00275	CcSEcCtD
Etodolac—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.00055	0.00274	CcSEcCtD
Etodolac—Flushing—Carmustine—melanoma	0.00055	0.00274	CcSEcCtD
Etodolac—Ill-defined disorder—Bleomycin—melanoma	0.000548	0.00273	CcSEcCtD
Etodolac—Anaemia—Bleomycin—melanoma	0.000546	0.00272	CcSEcCtD
Etodolac—Diarrhoea—Vemurafenib—melanoma	0.000544	0.00271	CcSEcCtD
Etodolac—Erythema multiforme—Temozolomide—melanoma	0.000541	0.0027	CcSEcCtD
Etodolac—Tinnitus—Temozolomide—melanoma	0.000534	0.00266	CcSEcCtD
Etodolac—Malaise—Bleomycin—melanoma	0.000533	0.00266	CcSEcCtD
Etodolac—Flushing—Temozolomide—melanoma	0.000531	0.00265	CcSEcCtD
Etodolac—Arrhythmia—Carmustine—melanoma	0.000529	0.00264	CcSEcCtD
Etodolac—Leukopenia—Bleomycin—melanoma	0.000529	0.00264	CcSEcCtD
Etodolac—Dizziness—Vemurafenib—melanoma	0.000526	0.00262	CcSEcCtD
Etodolac—Alopecia—Carmustine—melanoma	0.000523	0.00261	CcSEcCtD
Etodolac—Chills—Temozolomide—melanoma	0.000514	0.00256	CcSEcCtD
Etodolac—Ill-defined disorder—Dactinomycin—melanoma	0.000511	0.00255	CcSEcCtD
Etodolac—Anaemia—Dactinomycin—melanoma	0.000509	0.00254	CcSEcCtD
Etodolac—Vomiting—Vemurafenib—melanoma	0.000506	0.00252	CcSEcCtD
Etodolac—Alopecia—Temozolomide—melanoma	0.000506	0.00252	CcSEcCtD
Etodolac—Myalgia—Bleomycin—melanoma	0.000503	0.00251	CcSEcCtD
Etodolac—Abdominal pain upper—Docetaxel—melanoma	0.000502	0.00251	CcSEcCtD
Etodolac—Rash—Vemurafenib—melanoma	0.000502	0.0025	CcSEcCtD
Etodolac—Dermatitis—Vemurafenib—melanoma	0.000501	0.0025	CcSEcCtD
Etodolac—Headache—Vemurafenib—melanoma	0.000498	0.00249	CcSEcCtD
Etodolac—Discomfort—Bleomycin—melanoma	0.000497	0.00248	CcSEcCtD
Etodolac—Malaise—Dactinomycin—melanoma	0.000497	0.00248	CcSEcCtD
Etodolac—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000495	0.00247	CcSEcCtD
Etodolac—Leukopenia—Dactinomycin—melanoma	0.000493	0.00246	CcSEcCtD
Etodolac—Dysgeusia—Temozolomide—melanoma	0.000488	0.00243	CcSEcCtD
Etodolac—Confusional state—Bleomycin—melanoma	0.000486	0.00242	CcSEcCtD
Etodolac—Vision blurred—Carmustine—melanoma	0.000486	0.00242	CcSEcCtD
Etodolac—Tremor—Carmustine—melanoma	0.000483	0.00241	CcSEcCtD
Etodolac—Oedema—Bleomycin—melanoma	0.000482	0.0024	CcSEcCtD
Etodolac—Anaphylactic shock—Bleomycin—melanoma	0.000482	0.0024	CcSEcCtD
Etodolac—Infection—Bleomycin—melanoma	0.000479	0.00239	CcSEcCtD
Etodolac—Anaemia—Carmustine—melanoma	0.000477	0.00238	CcSEcCtD
Etodolac—Nausea—Vemurafenib—melanoma	0.000473	0.00236	CcSEcCtD
Etodolac—Thrombocytopenia—Bleomycin—melanoma	0.000472	0.00235	CcSEcCtD
Etodolac—Vision blurred—Temozolomide—melanoma	0.00047	0.00234	CcSEcCtD
Etodolac—Myalgia—Dactinomycin—melanoma	0.000469	0.00234	CcSEcCtD
Etodolac—Bronchospasm—Docetaxel—melanoma	0.000468	0.00233	CcSEcCtD
Etodolac—Tremor—Temozolomide—melanoma	0.000467	0.00233	CcSEcCtD
Etodolac—Discomfort—Dactinomycin—melanoma	0.000463	0.00231	CcSEcCtD
Etodolac—Ill-defined disorder—Temozolomide—melanoma	0.000462	0.00231	CcSEcCtD
Etodolac—Leukopenia—Carmustine—melanoma	0.000461	0.0023	CcSEcCtD
Etodolac—Anaemia—Temozolomide—melanoma	0.00046	0.0023	CcSEcCtD
Etodolac—Anorexia—Bleomycin—melanoma	0.000459	0.00229	CcSEcCtD
Etodolac—Angioedema—Temozolomide—melanoma	0.000455	0.00227	CcSEcCtD
Etodolac—Pancytopenia—Docetaxel—melanoma	0.000452	0.00225	CcSEcCtD
Etodolac—Hypotension—Bleomycin—melanoma	0.00045	0.00225	CcSEcCtD
Etodolac—Oedema—Dactinomycin—melanoma	0.00045	0.00224	CcSEcCtD
Etodolac—Malaise—Temozolomide—melanoma	0.000449	0.00224	CcSEcCtD
Etodolac—Vertigo—Temozolomide—melanoma	0.000448	0.00223	CcSEcCtD
Etodolac—Convulsion—Carmustine—melanoma	0.000447	0.00223	CcSEcCtD
Etodolac—Infection—Dactinomycin—melanoma	0.000447	0.00223	CcSEcCtD
Etodolac—Leukopenia—Temozolomide—melanoma	0.000446	0.00222	CcSEcCtD
Etodolac—Hypertension—Carmustine—melanoma	0.000445	0.00222	CcSEcCtD
Etodolac—Neutropenia—Docetaxel—melanoma	0.000445	0.00222	CcSEcCtD
Etodolac—Palpitations—Temozolomide—melanoma	0.00044	0.0022	CcSEcCtD
Etodolac—Thrombocytopenia—Dactinomycin—melanoma	0.00044	0.0022	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Bleomycin—melanoma	0.000439	0.00219	CcSEcCtD
Etodolac—Myalgia—Carmustine—melanoma	0.000439	0.00219	CcSEcCtD
Etodolac—Anxiety—Carmustine—melanoma	0.000437	0.00218	CcSEcCtD
Etodolac—Paraesthesia—Bleomycin—melanoma	0.000433	0.00216	CcSEcCtD
Etodolac—Convulsion—Temozolomide—melanoma	0.000432	0.00215	CcSEcCtD
Etodolac—Hypertension—Temozolomide—melanoma	0.00043	0.00215	CcSEcCtD
Etodolac—Dyspnoea—Bleomycin—melanoma	0.00043	0.00214	CcSEcCtD
Etodolac—Anorexia—Dactinomycin—melanoma	0.000429	0.00214	CcSEcCtD
Etodolac—Pneumonia—Docetaxel—melanoma	0.000426	0.00213	CcSEcCtD
Etodolac—Confusional state—Carmustine—melanoma	0.000424	0.00212	CcSEcCtD
Etodolac—Myalgia—Temozolomide—melanoma	0.000424	0.00212	CcSEcCtD
Etodolac—Arthralgia—Temozolomide—melanoma	0.000424	0.00212	CcSEcCtD
Etodolac—Anxiety—Temozolomide—melanoma	0.000423	0.00211	CcSEcCtD
Etodolac—Oedema—Carmustine—melanoma	0.000421	0.0021	CcSEcCtD
Etodolac—Stevens-Johnson syndrome—Docetaxel—melanoma	0.00042	0.0021	CcSEcCtD
Etodolac—Discomfort—Temozolomide—melanoma	0.000419	0.00209	CcSEcCtD
Etodolac—Decreased appetite—Bleomycin—melanoma	0.000419	0.00209	CcSEcCtD
Etodolac—Infection—Carmustine—melanoma	0.000418	0.00208	CcSEcCtD
Etodolac—Acute coronary syndrome—Docetaxel—melanoma	0.000418	0.00208	CcSEcCtD
Etodolac—Renal failure—Docetaxel—melanoma	0.000417	0.00208	CcSEcCtD
Etodolac—Myocardial infarction—Docetaxel—melanoma	0.000416	0.00207	CcSEcCtD
Etodolac—Dry mouth—Temozolomide—melanoma	0.000415	0.00207	CcSEcCtD
Etodolac—Jaundice—Docetaxel—melanoma	0.000413	0.00206	CcSEcCtD
Etodolac—Stomatitis—Docetaxel—melanoma	0.000413	0.00206	CcSEcCtD
Etodolac—Pain—Bleomycin—melanoma	0.000412	0.00206	CcSEcCtD
Etodolac—Conjunctivitis—Docetaxel—melanoma	0.000412	0.00206	CcSEcCtD
Etodolac—Thrombocytopenia—Carmustine—melanoma	0.000412	0.00205	CcSEcCtD
Etodolac—Tachycardia—Carmustine—melanoma	0.000411	0.00205	CcSEcCtD
Etodolac—Confusional state—Temozolomide—melanoma	0.00041	0.00204	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00041	0.00204	CcSEcCtD
Etodolac—Anaphylactic shock—Temozolomide—melanoma	0.000407	0.00203	CcSEcCtD
Etodolac—Oedema—Temozolomide—melanoma	0.000407	0.00203	CcSEcCtD
Etodolac—Infection—Temozolomide—melanoma	0.000404	0.00201	CcSEcCtD
Etodolac—Anorexia—Carmustine—melanoma	0.000401	0.002	CcSEcCtD
Etodolac—Thrombocytopenia—Temozolomide—melanoma	0.000398	0.00199	CcSEcCtD
Etodolac—Feeling abnormal—Bleomycin—melanoma	0.000397	0.00198	CcSEcCtD
Etodolac—Agranulocytosis—Docetaxel—melanoma	0.000396	0.00197	CcSEcCtD
Etodolac—Hypotension—Carmustine—melanoma	0.000393	0.00196	CcSEcCtD
Etodolac—Hyperhidrosis—Temozolomide—melanoma	0.000393	0.00196	CcSEcCtD
Etodolac—Decreased appetite—Dactinomycin—melanoma	0.000391	0.00195	CcSEcCtD
Etodolac—Fatigue—Dactinomycin—melanoma	0.000388	0.00193	CcSEcCtD
Etodolac—Anorexia—Temozolomide—melanoma	0.000388	0.00193	CcSEcCtD
Etodolac—Pain—Dactinomycin—melanoma	0.000384	0.00192	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Carmustine—melanoma	0.000383	0.00191	CcSEcCtD
Etodolac—Urticaria—Bleomycin—melanoma	0.000383	0.00191	CcSEcCtD
Etodolac—Haemoglobin—Docetaxel—melanoma	0.000383	0.00191	CcSEcCtD
Etodolac—Rhinitis—Docetaxel—melanoma	0.000382	0.0019	CcSEcCtD
Etodolac—Body temperature increased—Bleomycin—melanoma	0.000381	0.0019	CcSEcCtD
Etodolac—Hepatitis—Docetaxel—melanoma	0.000381	0.0019	CcSEcCtD
Etodolac—Haemorrhage—Docetaxel—melanoma	0.000381	0.0019	CcSEcCtD
Etodolac—Insomnia—Carmustine—melanoma	0.000381	0.0019	CcSEcCtD
Etodolac—Paraesthesia—Carmustine—melanoma	0.000378	0.00188	CcSEcCtD
Etodolac—Pharyngitis—Docetaxel—melanoma	0.000378	0.00188	CcSEcCtD
Etodolac—Dyspnoea—Carmustine—melanoma	0.000375	0.00187	CcSEcCtD
Etodolac—Somnolence—Carmustine—melanoma	0.000374	0.00187	CcSEcCtD
Etodolac—Feeling abnormal—Dactinomycin—melanoma	0.00037	0.00185	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Temozolomide—melanoma	0.00037	0.00185	CcSEcCtD
Etodolac—Insomnia—Temozolomide—melanoma	0.000368	0.00183	CcSEcCtD
Etodolac—Gastrointestinal pain—Dactinomycin—melanoma	0.000368	0.00183	CcSEcCtD
Etodolac—Visual impairment—Docetaxel—melanoma	0.000367	0.00183	CcSEcCtD
Etodolac—Decreased appetite—Carmustine—melanoma	0.000366	0.00182	CcSEcCtD
Etodolac—Paraesthesia—Temozolomide—melanoma	0.000365	0.00182	CcSEcCtD
Etodolac—Dyspnoea—Temozolomide—melanoma	0.000363	0.00181	CcSEcCtD
Etodolac—Somnolence—Temozolomide—melanoma	0.000361	0.0018	CcSEcCtD
Etodolac—Erythema multiforme—Docetaxel—melanoma	0.00036	0.00179	CcSEcCtD
Etodolac—Constipation—Carmustine—melanoma	0.00036	0.00179	CcSEcCtD
Etodolac—Pain—Carmustine—melanoma	0.00036	0.00179	CcSEcCtD
Etodolac—Dyspepsia—Temozolomide—melanoma	0.000358	0.00179	CcSEcCtD
Etodolac—Abdominal pain—Dactinomycin—melanoma	0.000355	0.00177	CcSEcCtD
Etodolac—Body temperature increased—Dactinomycin—melanoma	0.000355	0.00177	CcSEcCtD
Etodolac—Hypersensitivity—Bleomycin—melanoma	0.000355	0.00177	CcSEcCtD
Etodolac—Decreased appetite—Temozolomide—melanoma	0.000353	0.00176	CcSEcCtD
Etodolac—Flushing—Docetaxel—melanoma	0.000353	0.00176	CcSEcCtD
Etodolac—Fatigue—Temozolomide—melanoma	0.000351	0.00175	CcSEcCtD
Etodolac—Pain—Temozolomide—melanoma	0.000348	0.00173	CcSEcCtD
Etodolac—Constipation—Temozolomide—melanoma	0.000348	0.00173	CcSEcCtD
Etodolac—Feeling abnormal—Carmustine—melanoma	0.000347	0.00173	CcSEcCtD
Etodolac—Asthenia—Bleomycin—melanoma	0.000346	0.00172	CcSEcCtD
Etodolac—Gastrointestinal pain—Carmustine—melanoma	0.000344	0.00172	CcSEcCtD
Etodolac—Chills—Docetaxel—melanoma	0.000342	0.0017	CcSEcCtD
Etodolac—Pruritus—Bleomycin—melanoma	0.000341	0.0017	CcSEcCtD
Etodolac—Arrhythmia—Docetaxel—melanoma	0.00034	0.0017	CcSEcCtD
Etodolac—Alopecia—Docetaxel—melanoma	0.000336	0.00168	CcSEcCtD
Etodolac—Feeling abnormal—Temozolomide—melanoma	0.000335	0.00167	CcSEcCtD
Etodolac—Body temperature increased—Carmustine—melanoma	0.000333	0.00166	CcSEcCtD
Etodolac—Abdominal pain—Carmustine—melanoma	0.000333	0.00166	CcSEcCtD
Etodolac—Gastrointestinal pain—Temozolomide—melanoma	0.000332	0.00166	CcSEcCtD
Etodolac—Hypersensitivity—Dactinomycin—melanoma	0.000331	0.00165	CcSEcCtD
Etodolac—Dysgeusia—Docetaxel—melanoma	0.000324	0.00162	CcSEcCtD
Etodolac—Urticaria—Temozolomide—melanoma	0.000323	0.00161	CcSEcCtD
Etodolac—Asthenia—Dactinomycin—melanoma	0.000323	0.00161	CcSEcCtD
Etodolac—Body temperature increased—Temozolomide—melanoma	0.000321	0.0016	CcSEcCtD
Etodolac—Abdominal pain—Temozolomide—melanoma	0.000321	0.0016	CcSEcCtD
Etodolac—Hypersensitivity—Carmustine—melanoma	0.00031	0.00155	CcSEcCtD
Etodolac—Diarrhoea—Dactinomycin—melanoma	0.000308	0.00153	CcSEcCtD
Etodolac—Vomiting—Bleomycin—melanoma	0.000306	0.00153	CcSEcCtD
Etodolac—Anaemia—Docetaxel—melanoma	0.000306	0.00153	CcSEcCtD
Etodolac—Rash—Bleomycin—melanoma	0.000304	0.00152	CcSEcCtD
Etodolac—Dermatitis—Bleomycin—melanoma	0.000304	0.00151	CcSEcCtD
Etodolac—Asthenia—Carmustine—melanoma	0.000302	0.00151	CcSEcCtD
Etodolac—Hypersensitivity—Temozolomide—melanoma	0.0003	0.00149	CcSEcCtD
Etodolac—Syncope—Docetaxel—melanoma	0.000297	0.00148	CcSEcCtD
Etodolac—Leukopenia—Docetaxel—melanoma	0.000297	0.00148	CcSEcCtD
Etodolac—Palpitations—Docetaxel—melanoma	0.000293	0.00146	CcSEcCtD
Etodolac—Asthenia—Temozolomide—melanoma	0.000292	0.00145	CcSEcCtD
Etodolac—Loss of consciousness—Docetaxel—melanoma	0.000291	0.00145	CcSEcCtD
Etodolac—Diarrhoea—Carmustine—melanoma	0.000288	0.00144	CcSEcCtD
Etodolac—Pruritus—Temozolomide—melanoma	0.000288	0.00143	CcSEcCtD
Etodolac—Convulsion—Docetaxel—melanoma	0.000287	0.00143	CcSEcCtD
Etodolac—Nausea—Bleomycin—melanoma	0.000286	0.00143	CcSEcCtD
Etodolac—Hypertension—Docetaxel—melanoma	0.000286	0.00143	CcSEcCtD
Etodolac—Vomiting—Dactinomycin—melanoma	0.000286	0.00143	CcSEcCtD
Etodolac—Rash—Dactinomycin—melanoma	0.000283	0.00141	CcSEcCtD
Etodolac—Arthralgia—Docetaxel—melanoma	0.000282	0.00141	CcSEcCtD
Etodolac—Myalgia—Docetaxel—melanoma	0.000282	0.00141	CcSEcCtD
Etodolac—Dizziness—Carmustine—melanoma	0.000278	0.00139	CcSEcCtD
Etodolac—Diarrhoea—Temozolomide—melanoma	0.000278	0.00139	CcSEcCtD
Etodolac—Dry mouth—Docetaxel—melanoma	0.000276	0.00138	CcSEcCtD
Etodolac—Confusional state—Docetaxel—melanoma	0.000273	0.00136	CcSEcCtD
Etodolac—Anaphylactic shock—Docetaxel—melanoma	0.00027	0.00135	CcSEcCtD
Etodolac—Oedema—Docetaxel—melanoma	0.00027	0.00135	CcSEcCtD
Etodolac—Dizziness—Temozolomide—melanoma	0.000269	0.00134	CcSEcCtD
Etodolac—Infection—Docetaxel—melanoma	0.000269	0.00134	CcSEcCtD
Etodolac—Vomiting—Carmustine—melanoma	0.000268	0.00133	CcSEcCtD
Etodolac—Nausea—Dactinomycin—melanoma	0.000267	0.00133	CcSEcCtD
Etodolac—Shock—Docetaxel—melanoma	0.000266	0.00133	CcSEcCtD
Etodolac—Rash—Carmustine—melanoma	0.000265	0.00132	CcSEcCtD
Etodolac—Dermatitis—Carmustine—melanoma	0.000265	0.00132	CcSEcCtD
Etodolac—Thrombocytopenia—Docetaxel—melanoma	0.000265	0.00132	CcSEcCtD
Etodolac—Tachycardia—Docetaxel—melanoma	0.000264	0.00132	CcSEcCtD
Etodolac—Headache—Carmustine—melanoma	0.000264	0.00131	CcSEcCtD
Etodolac—Vomiting—Temozolomide—melanoma	0.000259	0.00129	CcSEcCtD
Etodolac—Anorexia—Docetaxel—melanoma	0.000258	0.00129	CcSEcCtD
Etodolac—Rash—Temozolomide—melanoma	0.000256	0.00128	CcSEcCtD
Etodolac—Dermatitis—Temozolomide—melanoma	0.000256	0.00128	CcSEcCtD
Etodolac—Headache—Temozolomide—melanoma	0.000255	0.00127	CcSEcCtD
Etodolac—Hypotension—Docetaxel—melanoma	0.000253	0.00126	CcSEcCtD
Etodolac—Nausea—Carmustine—melanoma	0.00025	0.00125	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Docetaxel—melanoma	0.000246	0.00123	CcSEcCtD
Etodolac—Insomnia—Docetaxel—melanoma	0.000245	0.00122	CcSEcCtD
Etodolac—Paraesthesia—Docetaxel—melanoma	0.000243	0.00121	CcSEcCtD
Etodolac—Nausea—Temozolomide—melanoma	0.000242	0.0012	CcSEcCtD
Etodolac—Dyspnoea—Docetaxel—melanoma	0.000241	0.0012	CcSEcCtD
Etodolac—Somnolence—Docetaxel—melanoma	0.00024	0.0012	CcSEcCtD
Etodolac—Dyspepsia—Docetaxel—melanoma	0.000238	0.00119	CcSEcCtD
Etodolac—Decreased appetite—Docetaxel—melanoma	0.000235	0.00117	CcSEcCtD
Etodolac—Fatigue—Docetaxel—melanoma	0.000233	0.00116	CcSEcCtD
Etodolac—Pain—Docetaxel—melanoma	0.000231	0.00115	CcSEcCtD
Etodolac—Constipation—Docetaxel—melanoma	0.000231	0.00115	CcSEcCtD
Etodolac—Feeling abnormal—Docetaxel—melanoma	0.000223	0.00111	CcSEcCtD
Etodolac—Gastrointestinal pain—Docetaxel—melanoma	0.000221	0.0011	CcSEcCtD
Etodolac—Abdominal pain—Docetaxel—melanoma	0.000214	0.00107	CcSEcCtD
Etodolac—Body temperature increased—Docetaxel—melanoma	0.000214	0.00107	CcSEcCtD
Etodolac—Hypersensitivity—Docetaxel—melanoma	0.000199	0.000994	CcSEcCtD
Etodolac—Asthenia—Docetaxel—melanoma	0.000194	0.000968	CcSEcCtD
Etodolac—Pruritus—Docetaxel—melanoma	0.000191	0.000954	CcSEcCtD
Etodolac—Diarrhoea—Docetaxel—melanoma	0.000185	0.000923	CcSEcCtD
Etodolac—Dizziness—Docetaxel—melanoma	0.000179	0.000892	CcSEcCtD
Etodolac—Vomiting—Docetaxel—melanoma	0.000172	0.000857	CcSEcCtD
Etodolac—Rash—Docetaxel—melanoma	0.00017	0.00085	CcSEcCtD
Etodolac—Dermatitis—Docetaxel—melanoma	0.00017	0.00085	CcSEcCtD
Etodolac—Headache—Docetaxel—melanoma	0.000169	0.000845	CcSEcCtD
Etodolac—Nausea—Docetaxel—melanoma	0.000161	0.000801	CcSEcCtD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	2.43e-05	0.000134	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.41e-05	0.000133	CbGpPWpGaD
Etodolac—RXRA—Metabolism—ABCB1—melanoma	2.39e-05	0.000131	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—ALB—melanoma	2.38e-05	0.000131	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—melanoma	2.36e-05	0.00013	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PRKCA—melanoma	2.35e-05	0.00013	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—ERCC2—melanoma	2.34e-05	0.000128	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—MAPK1—melanoma	2.33e-05	0.000128	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—EGFR—melanoma	2.33e-05	0.000128	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—ABCB1—melanoma	2.32e-05	0.000128	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—GNA11—melanoma	2.31e-05	0.000127	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—VCAN—melanoma	2.3e-05	0.000127	CbGpPWpGaD
Etodolac—ALB—Hemostasis—RAC1—melanoma	2.29e-05	0.000126	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—NOTCH1—melanoma	2.26e-05	0.000124	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—FASN—melanoma	2.26e-05	0.000124	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—VEGFA—melanoma	2.25e-05	0.000124	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.23e-05	0.000123	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—SLC5A5—melanoma	2.22e-05	0.000122	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—TNF—melanoma	2.22e-05	0.000122	CbGpPWpGaD
Etodolac—ALB—Hemostasis—MMP1—melanoma	2.22e-05	0.000122	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PHGDH—melanoma	2.22e-05	0.000122	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—LUM—melanoma	2.22e-05	0.000122	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—KRAS—melanoma	2.2e-05	0.000121	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PRKCA—melanoma	2.2e-05	0.000121	CbGpPWpGaD
Etodolac—PTGS2—Disease—GAB2—melanoma	2.19e-05	0.00012	CbGpPWpGaD
Etodolac—RXRA—Metabolism—ERCC2—melanoma	2.18e-05	0.00012	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.18e-05	0.00012	CbGpPWpGaD
Etodolac—ALB—Hemostasis—CDK2—melanoma	2.18e-05	0.00012	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—HPSE—melanoma	2.17e-05	0.00012	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PIK3CG—melanoma	2.17e-05	0.000119	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CD44—melanoma	2.15e-05	0.000118	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—GNAQ—melanoma	2.15e-05	0.000118	CbGpPWpGaD
Etodolac—PTGS2—Disease—FASN—melanoma	2.14e-05	0.000118	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—PPARG—melanoma	2.14e-05	0.000117	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CUBN—melanoma	2.13e-05	0.000117	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—MAPK3—melanoma	2.12e-05	0.000117	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.1e-05	0.000116	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.1e-05	0.000116	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PPARG—melanoma	2.09e-05	0.000115	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.08e-05	0.000115	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—ABCB1—melanoma	2.08e-05	0.000114	CbGpPWpGaD
Etodolac—ALB—Metabolism—PLA2G6—melanoma	2.07e-05	0.000114	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—SDHD—melanoma	2.06e-05	0.000113	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CSPG4—melanoma	2.06e-05	0.000113	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—BSG—melanoma	2.06e-05	0.000113	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CYP1B1—melanoma	2.06e-05	0.000113	CbGpPWpGaD
Etodolac—PTGS2—Disease—HDAC2—melanoma	2.06e-05	0.000113	CbGpPWpGaD
Etodolac—PTGS2—Disease—CXCR4—melanoma	2.06e-05	0.000113	CbGpPWpGaD
Etodolac—PTGS2—Disease—FOXO4—melanoma	2.06e-05	0.000113	CbGpPWpGaD
Etodolac—PTGS2—Disease—CD44—melanoma	2.03e-05	0.000112	CbGpPWpGaD
Etodolac—ALB—Hemostasis—FN1—melanoma	2.02e-05	0.000111	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—MAPK1—melanoma	2.02e-05	0.000111	CbGpPWpGaD
Etodolac—ALB—Hemostasis—NOS2—melanoma	2e-05	0.00011	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GPAM—melanoma	1.99e-05	0.00011	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1.99e-05	0.000109	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CYP17A1—melanoma	1.94e-05	0.000107	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PIK3CG—melanoma	1.94e-05	0.000106	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.91e-05	0.000105	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PRKCA—melanoma	1.91e-05	0.000105	CbGpPWpGaD
Etodolac—ALB—Hemostasis—EGF—melanoma	1.91e-05	0.000105	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PIK3CD—melanoma	1.91e-05	0.000105	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—ERCC2—melanoma	1.9e-05	0.000104	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—ALB—melanoma	1.89e-05	0.000104	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—ALB—melanoma	1.88e-05	0.000104	CbGpPWpGaD
Etodolac—PTGS2—Disease—AKT3—melanoma	1.88e-05	0.000103	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—HRAS—melanoma	1.87e-05	0.000103	CbGpPWpGaD
Etodolac—ALB—Metabolism—VCAN—melanoma	1.86e-05	0.000102	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PIK3CG—melanoma	1.84e-05	0.000101	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GNA11—melanoma	1.83e-05	0.000101	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.82e-05	9.99e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.8e-05	9.92e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—FASN—melanoma	1.79e-05	9.87e-05	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—IL6—melanoma	1.79e-05	9.84e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PPARG—melanoma	1.78e-05	9.79e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—IGF1—melanoma	1.77e-05	9.75e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—SLC5A5—melanoma	1.76e-05	9.71e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.76e-05	9.69e-05	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—PIK3CA—melanoma	1.75e-05	9.65e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PIK3CG—melanoma	1.72e-05	9.46e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GNAQ—melanoma	1.7e-05	9.37e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CD44—melanoma	1.7e-05	9.37e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PIK3CD—melanoma	1.7e-05	9.36e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.7e-05	9.35e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PLA2G6—melanoma	1.7e-05	9.33e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—ABCB1—melanoma	1.69e-05	9.32e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.67e-05	9.18e-05	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PIK3CB—melanoma	1.66e-05	9.14e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PPARG—melanoma	1.66e-05	9.13e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—ERBB4—melanoma	1.66e-05	9.12e-05	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—AKT1—melanoma	1.65e-05	9.08e-05	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PTGS2—melanoma	1.65e-05	9.06e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—CDKN2B—melanoma	1.64e-05	9.04e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CYP1B1—melanoma	1.63e-05	8.99e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PIK3CD—melanoma	1.62e-05	8.92e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—ALB—melanoma	1.6e-05	8.8e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—CD86—melanoma	1.59e-05	8.75e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.57e-05	8.65e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—CYP17A1—melanoma	1.57e-05	8.64e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PRKCA—melanoma	1.56e-05	8.58e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.55e-05	8.52e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—ERCC2—melanoma	1.55e-05	8.51e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—FGF1—melanoma	1.54e-05	8.48e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—VCAN—melanoma	1.52e-05	8.38e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PIK3CD—melanoma	1.51e-05	8.32e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PIK3CG—melanoma	1.5e-05	8.24e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—PDGFRA—melanoma	1.49e-05	8.22e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—ALB—melanoma	1.49e-05	8.21e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—GNA11—melanoma	1.48e-05	8.16e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PIK3CB—melanoma	1.48e-05	8.16e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—PRKCA—melanoma	1.48e-05	8.13e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—ERCC2—melanoma	1.47e-05	8.07e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—FASN—melanoma	1.45e-05	7.98e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PPARG—melanoma	1.45e-05	7.96e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—MAP2K2—melanoma	1.45e-05	7.95e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.44e-05	7.93e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.44e-05	7.93e-05	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PTEN—melanoma	1.44e-05	7.9e-05	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—AKT1—melanoma	1.43e-05	7.88e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—SLC5A5—melanoma	1.43e-05	7.85e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PIK3CB—melanoma	1.41e-05	7.77e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PTGS2—melanoma	1.4e-05	7.7e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.39e-05	7.66e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—GNAQ—melanoma	1.38e-05	7.58e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—CD44—melanoma	1.38e-05	7.58e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—TERT—melanoma	1.37e-05	7.56e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—HLA-A—melanoma	1.37e-05	7.56e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—RAC1—melanoma	1.37e-05	7.54e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—IL2—melanoma	1.36e-05	7.49e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.35e-05	7.43e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—ABCB1—melanoma	1.35e-05	7.4e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.34e-05	7.36e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—CYP1B1—melanoma	1.32e-05	7.27e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PIK3CB—melanoma	1.32e-05	7.25e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PIK3CD—melanoma	1.32e-05	7.25e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—HIF1A—melanoma	1.31e-05	7.23e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PTGS2—melanoma	1.31e-05	7.18e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—ALB—melanoma	1.3e-05	7.15e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CYP17A1—melanoma	1.29e-05	7.07e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.28e-05	7.05e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.27e-05	6.97e-05	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—MAPK3—melanoma	1.25e-05	6.88e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	1.25e-05	6.88e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PRKCA—melanoma	1.24e-05	6.81e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—ERCC2—melanoma	1.23e-05	6.75e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PIK3CG—melanoma	1.22e-05	6.72e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PTEN—melanoma	1.22e-05	6.72e-05	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—MYC—melanoma	1.22e-05	6.7e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GNA11—melanoma	1.21e-05	6.68e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—NOS2—melanoma	1.2e-05	6.58e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—FASN—melanoma	1.19e-05	6.53e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—NOTCH1—melanoma	1.18e-05	6.51e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PPARG—melanoma	1.18e-05	6.49e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—SLC5A5—melanoma	1.17e-05	6.43e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.17e-05	6.42e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—CD80—melanoma	1.16e-05	6.38e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—KIT—melanoma	1.16e-05	6.37e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—APC—melanoma	1.16e-05	6.37e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—VEGFA—melanoma	1.16e-05	6.37e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PIK3CB—melanoma	1.15e-05	6.32e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—EGF—melanoma	1.14e-05	6.3e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—NRAS—melanoma	1.14e-05	6.29e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PTEN—melanoma	1.14e-05	6.27e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PTGS2—melanoma	1.14e-05	6.26e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GNAQ—melanoma	1.13e-05	6.21e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CD44—melanoma	1.13e-05	6.21e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.11e-05	6.08e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.09e-05	6.02e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—MAPK3—melanoma	1.09e-05	6.02e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—BRAF—melanoma	1.09e-05	5.99e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—ABCB1—melanoma	1.09e-05	5.99e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CYP1B1—melanoma	1.08e-05	5.95e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PIK3CD—melanoma	1.07e-05	5.91e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—ALB—melanoma	1.06e-05	5.83e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—MAPK1—melanoma	1.04e-05	5.73e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—MAP2K1—melanoma	1.02e-05	5.64e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—PIK3CD—melanoma	1.02e-05	5.6e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.02e-05	5.6e-05	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PIK3CA—melanoma	1.01e-05	5.57e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PRKCA—melanoma	1e-05	5.51e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—ERCC2—melanoma	9.94e-06	5.46e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PTEN—melanoma	9.92e-06	5.46e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—KRAS—melanoma	9.84e-06	5.41e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—FGF2—melanoma	9.75e-06	5.36e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PIK3CG—melanoma	9.7e-06	5.33e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	9.55e-06	5.25e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PIK3CB—melanoma	9.36e-06	5.15e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PPARG—melanoma	9.36e-06	5.15e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PTGS2—melanoma	9.28e-06	5.1e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—MDM2—melanoma	9.12e-06	5.02e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PIK3CA—melanoma	9.04e-06	4.97e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—ERBB2—melanoma	8.99e-06	4.95e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ABCB1—melanoma	8.91e-06	4.9e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—PIK3CB—melanoma	8.87e-06	4.88e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—CD4—melanoma	8.86e-06	4.87e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—TP53—melanoma	8.75e-06	4.81e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PIK3CA—melanoma	8.61e-06	4.74e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PIK3CD—melanoma	8.53e-06	4.69e-05	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—AKT1—melanoma	8.44e-06	4.64e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—ALB—melanoma	8.42e-06	4.63e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—HRAS—melanoma	8.36e-06	4.6e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—CDKN1B—melanoma	8.33e-06	4.58e-05	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—AKT1—melanoma	8.28e-06	4.55e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	8.23e-06	4.53e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PRKCA—melanoma	8.2e-06	4.51e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ERCC2—melanoma	8.13e-06	4.47e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PTEN—melanoma	8.09e-06	4.45e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PIK3CA—melanoma	8.04e-06	4.42e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—CTNNB1—melanoma	7.87e-06	4.33e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PIK3CG—melanoma	7.85e-06	4.32e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—CDKN1A—melanoma	7.69e-06	4.23e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—PTEN—melanoma	7.67e-06	4.22e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PPARG—melanoma	7.57e-06	4.17e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PIK3CB—melanoma	7.43e-06	4.09e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—AKT1—melanoma	7.38e-06	4.06e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—AKT1—melanoma	7.04e-06	3.87e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PIK3CA—melanoma	7e-06	3.85e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PIK3CD—melanoma	6.9e-06	3.79e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—STAT3—melanoma	6.86e-06	3.77e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—NRAS—melanoma	6.84e-06	3.76e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.74e-06	3.71e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—AKT1—melanoma	6.56e-06	3.61e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—MAPK3—melanoma	6.55e-06	3.6e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PIK3CG—melanoma	6.42e-06	3.53e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PTEN—melanoma	6.42e-06	3.53e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—MYC—melanoma	6.37e-06	3.51e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—MAPK1—melanoma	6.23e-06	3.43e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—EGFR—melanoma	6.23e-06	3.43e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PPARG—melanoma	6.2e-06	3.41e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PIK3CB—melanoma	6.01e-06	3.31e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PTGS2—melanoma	5.96e-06	3.28e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—KRAS—melanoma	5.89e-06	3.24e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—AKT1—melanoma	5.72e-06	3.15e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PIK3CA—melanoma	5.71e-06	3.14e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PIK3CD—melanoma	5.65e-06	3.11e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ALB—melanoma	5.57e-06	3.07e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—PIK3CA—melanoma	5.41e-06	2.98e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PTEN—melanoma	5.2e-06	2.86e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—HRAS—melanoma	5e-06	2.75e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PIK3CB—melanoma	4.92e-06	2.71e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PTGS2—melanoma	4.88e-06	2.68e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—IL6—melanoma	4.79e-06	2.63e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—AKT1—melanoma	4.66e-06	2.56e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PIK3CA—melanoma	4.53e-06	2.49e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—AKT1—melanoma	4.42e-06	2.43e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PTEN—melanoma	4.25e-06	2.34e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—AKT1—melanoma	3.7e-06	2.04e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PIK3CA—melanoma	3.67e-06	2.02e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PIK3CA—melanoma	3e-06	1.65e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—AKT1—melanoma	2.99e-06	1.65e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—AKT1—melanoma	2.45e-06	1.35e-05	CbGpPWpGaD
